Hudson Bay Capital Management LP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1393825
STAMFORD, CT
Position in SUPN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,694,536
New position
Shares Held
90,821
first reported quarter
Ownership
0.156%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $123,784,198 across 12 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
395,850 | $52,149,278 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $27,000,000 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,918 | $12,403,955 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
364,212 | $11,101,181 | |
| 5 | ALKS |
Alkermes plc.
|
173,626 | $6,139,415 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
90,821 | $4,694,536 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
490,369 | $4,668,312 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
151,366 | $3,142,358 |
All Filings in SUPN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,694,536 | 90,821 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||